US Supply Chain Partners Get Details On Designing Information Security Systems
In draft guidance on evolving drug product tracking program, the US FDA gives thumbs-up on distributed or semi-distributed architecture for data security; support for aggregation and inference; a one-minute bar for verification.
You may also be interested in...
Roughly half of all pharmaceutical manufacturers have misgivings they will have the necessary systems to electronically verify saleable returns under DSCSA, even though they must respond to these requests within 24 hours.
International association of pharmaceutical inspectorates launches industry consultation on aligning with the one EU GMP provision it spurned years ago.
Two batches were authorized because they were made before production waste jammed Emergent BioSolutions' Bayview plant.